Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure
Fitish, a clean beauty brand founded by Jenna Owens, with a telehealth arm trading as Fitish RX
Fitish began as a clean beauty line and now sells provider-prescribed compounded GLP-1 programmes alongside skincare, in full-dose and microdose versions. Pricing is flat per monthly supply and stated to include the consultation, the medication and shipping, with no membership. Its published answer on HSA and FSA payment is more candid about what can go wrong at checkout than almost anything else in this directory.
Sources captured · researched by Tom
As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.
Fitish RX publishes 8 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers
These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.
Someone who wants one flat monthly figure with nothing added at checkout, and who is considering a microdose rather than full-dose therapy.
Sometimes, and the site says so directly. Its published answer is that card networks treat compounded telehealth prescriptions inconsistently, so a card can be declined at checkout even when your plan would cover the expense, and that eligibility is decided by your plan administrator rather than by Fitish. It suggests checking with the administrator, paying with another card and claiming reimbursement, with a Letter of Medical Necessity from the provider to support it. That is a more useful answer than the usual two-word 'HSA accepted'.
Fitish describes it as a lower fixed dose that does not titrate upward, for people who want a gentle or cosmetic effect rather than full weight management. It costs less than the full-dose programme. What it does not have is trial evidence — the published research on semaglutide and tirzepatide for weight loss studied full titrated doses of the branded products. Treat it as a dosing preference to discuss with the provider, not as an established protocol.
That is the published claim for compounded semaglutide: $219 a monthly supply, including the provider consult, the medication if approved, and shipping, with no separate consult or membership fee. Tirzepatide is $339 on the same basis. What is not published is what happens to that money if you stop, so ask for the refund terms before the first charge.
Captured . Pages change — check the current version before relying on anything here.
Cora Health, with clinical services delivered through the Wasef Health provider network
Names both of its compounding pharmacies and publishes the whole price ladder, not a 'starting at' figure
Coby Health LLC, described as operating a marketplace and patient management system rather than providing medical or pharmacy services itself
Pay-as-you-go compounded GLP-1s with a published dose-by-dose price ladder and no subscription
Curex
No membership fee at all — one inclusive price covering prescription and medication